Page last updated: 2024-10-22

amitriptyline and Cell Transformation, Neoplastic

amitriptyline has been researched along with Cell Transformation, Neoplastic in 1 studies

Amitriptyline: Tricyclic antidepressant with anticholinergic and sedative properties. It appears to prevent the re-uptake of norepinephrine and serotonin at nerve terminals, thus potentiating the action of these neurotransmitters. Amitriptyline also appears to antagonize cholinergic and alpha-1 adrenergic responses to bioactive amines.
amitriptyline : An organic tricyclic compound that is 10,11-dihydro-5H-dibenzo[a,d][7]annulene substituted by a 3-(dimethylamino)propylidene group at position 5.

Cell Transformation, Neoplastic: Cell changes manifested by escape from control mechanisms, increased growth potential, alterations in the cell surface, karyotypic abnormalities, morphological and biochemical deviations from the norm, and other attributes conferring the ability to invade, metastasize, and kill.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Evason, KJ1
Francisco, MT1
Juric, V1
Balakrishnan, S1
Lopez Pazmino, Mdel P1
Gordan, JD1
Kakar, S1
Spitsbergen, J1
Goga, A1
Stainier, DY1

Other Studies

1 other study available for amitriptyline and Cell Transformation, Neoplastic

ArticleYear
Identification of Chemical Inhibitors of β-Catenin-Driven Liver Tumorigenesis in Zebrafish.
    PLoS genetics, 2015, Volume: 11, Issue:7

    Topics: Amitriptyline; Animals; Animals, Genetically Modified; Antidepressive Agents, Tricyclic; beta Cateni

2015